Prevalence and correlation of conventional and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients

被引:30
|
作者
Yang, L. [1 ]
Tao, J. [1 ]
Tang, X. [2 ]
Wang, Y. [1 ]
He, X. [1 ]
Xu, G. [1 ]
Ren, Y. [1 ]
Tu, Y. [1 ]
机构
[1] Huazhong Univ Sci & Technol, Affiliated Union Hosp, Tongji Med Coll, Dept Dermatol, Wuhan 430074, Hubei Province, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Div Rheumatol, Hong Kong, Hong Kong, Peoples R China
基金
中国国家自然科学基金;
关键词
CORONARY-HEART-DISEASE; ACCELERATED ATHEROSCLEROSIS; ARTERY; WOMEN; STROKE;
D O I
10.1111/j.1468-3083.2011.04211.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background It has become clear that the morbidity and mortality of patients with lupus and cardiovascular disease (CVD) have substantially increased. Therefore, we designed a retrospective casecontrol study to assess the prevalence of traditional and lupus-specific risk factors for CVD in Chinese systemic lupus erythematosus (SLE) patients. Objective To identify the prevalence and correlation of conventional and lupus-specific risk factors for CVD in Chinese SLE patients. Methods One hundred and thirty-nine patients with SLE were enrolled in the study. They were compared with 139 age and gender-matched controls, who had no history of SLE or CVD. Among 139 SLE patients, there were 38 with CVD. We compared them with 38 SLE patients without CVD, matching for disease duration and age. Data regarding classic and lupus-specific risk factors were assessed between the two groups. Results Hypertension, serum creatinine and diabetes mellitus were more prevalent among SLE than the controls (P < 0.05). The patients with SLE were more likely to have elevated total, low-density lipoprotein cholesterol and triglyceride levels than the controls (P < 0.001). However, high-density lipoprotein levels in SLE patients were lower than that in controls (P = 0.019). After being compared with SLE patients without CVD, the patients with both SLE and CVD were more likely to have elevated serum creatinine, proteinuria, the presence of anti-Sm antibody and decreased complement 4 (C4) levels (P < 0.05). Moreover, the patients with both diseases were less likely to be treated with hydroxychloroquine (P < 0.05). In multivariable analysis, elevated serum creatinine, proteinuria, decreased C4 levels, the presence of anti-Sm antibody and the lack of using hydroxychloroquine were independent risk factors for CVD (P < 0.05). Conclusions We are able to identify some conventional and lupus-specific risk factors for CVD in Chinese SLE patients.
引用
收藏
页码:95 / 101
页数:7
相关论文
共 50 条
  • [31] CARDIOVASCULAR RISK FACTORS IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH HYPERTENSION
    Baya, W.
    Anoun, J.
    Ben Hassine, I.
    Mzabi, A.
    Karmani, M.
    Ismail, F. Ben Fredj
    Rezgui, A.
    Kechrid, C. Laouani
    JOURNAL OF HYPERTENSION, 2019, 37 : E169 - E169
  • [32] Epilepsy in systemic lupus erythematosus: prevalence and risk factors
    Hopia, L.
    Andersson, M.
    Svenungsson, E.
    Khademi, M.
    Piehl, F.
    Tomson, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 (02) : 297 - 307
  • [33] SUICIDAL IDEATION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: PREVALENCE AND RISK FACTORS
    Mok, C. C.
    Chan, K. K.
    Cheung, E.
    Yip, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 906 - 907
  • [34] PREVALENCE AND RISK FACTORS FOR MEMORY DYSFUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
    Shudim, S. S.
    Said, M. S. Mohamed
    Shaharir, S. S.
    Kong, N. C. T.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 474 - 474
  • [35] Profile of cardiovascular risk factors in patients with systemic Lupus erythematosus: The CArdiovascular Risk Assessment STudy in Lupus erythematosus (CASTLE SLE) study
    Fox, H.
    Jung, O.
    Bartel, C.
    Hauser, I. A.
    Ehrlich, J. R.
    JOURNAL FUR KARDIOLOGIE, 2018, 25 (5-6): : 128 - 134
  • [36] Cardiovascular disease risk and pathogenesis in systemic lupus erythematosus
    Oliveira, Christopher B.
    Kaplan, Mariana J.
    SEMINARS IN IMMUNOPATHOLOGY, 2022, 44 (03) : 309 - 324
  • [37] Cardiovascular disease risk and pathogenesis in systemic lupus erythematosus
    Christopher B. Oliveira
    Mariana J. Kaplan
    Seminars in Immunopathology, 2022, 44 : 309 - 324
  • [38] Prevalence of components of the metabolic syndrome in patients with systemic lupus erythematosus: Association with disease characteristics and cardiovascular risk factors.
    Chung, CP
    Oeser, A
    Avalos, I
    Stein, CM
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S604 - S604
  • [39] Prevalence of Cardiovascular Disease in a Populations Based Registry of Patients with Systemic Lupus Erythematosus
    Joyce, Daniel
    Berger, Jeffrey
    Guttmann, Allison
    Hasan, Ghadeer
    Buyon, Jill
    Belmont, H. Michael
    Salmon, Jane
    Askanase, Anca
    Bathon, Joan
    Geraldino-Pardilla, Laura
    Ali, Yousaf
    Ginzler, Ellen
    Putterman, Chaim
    Gordon, Caroline
    Helmick, Charles
    Barbour, Kamil
    Gold, Heather
    Parton, Hilary
    Izmirly, Peter
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2900 - 2902
  • [40] Systemic Lupus Erythematosus and Increased Prevalence of Atherosclerotic Cardiovascular Disease in Hospitalized Patients
    Katz, Gregory
    Smilowitz, Nathaniel R.
    Blazer, Ashira
    Clancy, Robert
    Buyon, Jill P.
    Berger, Jeffrey S.
    MAYO CLINIC PROCEEDINGS, 2019, 94 (08) : 1436 - 1443